Journey Medical 2026 shareholder meeting results filed
Journey Medical Corporation reported the results of its 2026 annual stockholder meeting held via virtual platform.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Journey Medical Corporation reported the results of its 2026 annual stockholder meeting held via virtual platform. Stockholders representing 16,145,526 shares of common stock and 6,000,000 shares of Class A common stock, together 81% of the 27,346,466 shares entitled to vote, were present, establishing a quorum.
All six director nominees were elected, each receiving over 31.7 million votes in favor, with broker non-votes of 6,515,971 for each nominee. Stockholders also ratified KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026, with 39,374,407 votes for, 50,168 against, and 202,042 abstentions.
8-K Event Classification
Key Figures
Key Terms
quorum financial
broker non-votes financial
independent registered public accounting firm financial
record date financial
proxy statement on Schedule 14A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Journey Medical (DERM) stockholders vote on at the 2026 annual meeting?
What percentage of Journey Medical (DERM) voting power was present at the 2026 meeting?
How many votes supported Journey Medical (DERM) director elections in 2026?
Was KPMG LLP ratified as Journey Medical (DERM) auditor for 2026?
What were Journey Medical (DERM) total votes eligible at the 2026 record date?
AI-generated analysis. How Rhea-AI works. Not financial advice.